Press Release regarding the receipt of Establishment Inspection Report (EIR) for the API Unit of the Company located in Chennai from U.S. Food and Drugs Administration (FDA)
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]